We are looking for a CEO for a pharmaceutical company with the ambition to be listed on First North stock exchange early 2022. The company was founded in 2018 and offer a product portfolio of generics- and specialty pharma medicines with a focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, product based on peptide technology as well as biosimilars in a variety of therapeutic categories. The first products are expected to be launched in the autumn of 2021. They have the ambition to become the local champion and alternative partner to the multinationals.
- Minimum five years’ work experience – in the pharmaceutical industry
- Experience from business development/commericial, pharmaceutical industry
- Experience in developing and executing marketing/sales strategies
If you have relevant experience please contact Ingmar Karlsson on my cellular: +46 709131331 or e-mail: email@example.com